Teva Pharmaceutical Industries (TEVA) Market Capitalization (2009 - 2026)

Teva Pharmaceutical Industries (TEVA) Market Capitalization (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn

Historic Data

Download Data
DateValue
Jul 23, 2026 39.60 Bn
Jul 22, 2026 38.31 Bn
Jul 21, 2026 39.86 Bn
Jul 20, 2026 39.40 Bn
Jul 17, 2026 40.70 Bn
Jul 16, 2026 40.98 Bn
Jul 15, 2026 40.11 Bn
Jul 14, 2026 40.44 Bn
Jul 13, 2026 40.88 Bn
Jul 10, 2026 41.84 Bn
Jul 9, 2026 42.08 Bn
Jul 8, 2026 42.24 Bn
Jul 7, 2026 44.01 Bn
Jul 6, 2026 44.85 Bn
Jul 2, 2026 44.03 Bn
Jul 1, 2026 42.51 Bn
Jun 30, 2026 43.06 Bn
Jun 29, 2026 42.34 Bn
Jun 26, 2026 42.21 Bn
Jun 26, 2026 42.21 Bn